Sadamu Homma

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells

Tetsuro Kikuchi, Yasuharu Akasaki, Masaki Irie et al. · Cancer Immunology Immunotherapy · 2001 · 273 citations · Full text

Medicine, Neuroscience, Oncology +16

Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes.

Nobuyuki Yamamoto, Sadamu Homma · Proceedings of the National Academy of Sciences · 1991 · 210 citations

Life Sciences, Biochemistry, Immunology +15

High plasma levels of soluble programmed cell death ligand 1 are prognostic for reduced survival in advanced lung cancer

Yusuke Okuma, Yukio Hosomi, Yoshiro Nakahara et al. · Lung Cancer · 2016 · 178 citations

Medicine, Cancer Biology, Oncology +13

Clinical and Immunologic Evaluation of Dendritic Cell–Based Immunotherapy in Combination With Gemcitabine and/or S-1 in Patients With Advanced Pancreatic Carcinoma

Yukino Kimura, Jun Tsukada, Takeshi Tomoda et al. · Pancreas · 2011 · 145 citations

Medicine, Immunology, Oncology +17

Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non–Small-cell Lung Cancer

Yusuke Okuma, Hiroshi Wakui, Hirofumi Utsumi et al. · Clinical Lung Cancer · 2018 · 145 citations

Medicine, Oncology, Pharmacology +16